Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.16 USD | +0.67% | +5.23% | +5.66% |
Jan. 02 | Ares Capital Prices $1 Billion of 2032 Notes | MT |
Dec. 20 | ADMA Biologics Repays $30 Million of Term Loan Facility | MT |
Capitalization | 14.86B 14.43B 13.54B 12.15B 21.39B 1,287B 23.89B 166B 61.55B 527B 55.75B 54.58B 2,308B | P/E ratio 2024 * |
9.36x | P/E ratio 2025 * | 10.4x |
---|---|---|---|---|---|
Enterprise value | 28.13B 27.32B 25.63B 22.99B 40.49B 2,436B 45.22B 313B 116B 997B 106B 103B 4,368B | EV / Sales 2024 * |
9.32x | EV / Sales 2025 * | 9.16x |
Free-Float |
99.18% | Yield 2024 * |
8.35% | Yield 2025 * | 8.36% |
Last Transcript: Ares Capital Corporation
1 day | +1.50% | ||
1 week | +4.12% | ||
Current month | +5.07% | ||
1 month | +7.38% | ||
3 months | +6.63% | ||
6 months | +9.42% | ||
Current year | +5.07% |
Director | Title | Age | Since |
---|---|---|---|
Kipp deVeer
CEO | Chief Executive Officer | 52 | 2014-06-30 |
Kort Schnabel
PSD | President | 48 | 2022-10-19 |
Mitch Goldstein
PSD | President | 58 | 2014-06-30 |
Manager | Title | Age | Since |
---|---|---|---|
Eric Siegel
BRD | Director/Board Member | 67 | 2003-12-31 |
Robert Rosen
BRD | Director/Board Member | 78 | 2003-12-31 |
Ann Bates
BRD | Director/Board Member | 67 | 2009-12-31 |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+1.50% | +4.12% | +13.97% | +7.28% | 14.86B | ||
0.00% | +2.91% | +14.64% | +30.70% | 9.38B | ||
+0.77% | +2.39% | +33.93% | +46.68% | 8.76B | ||
+0.16% | +0.90% | +2.60% | -26.10% | 6.63B | ||
+1.42% | +3.65% | +8.73% | -0.98% | 6.21B | ||
+0.19% | +2.58% | +33.33% | +30.96% | 5.37B | ||
+1.14% | +0.78% | +44.16% | +65.09% | 5.12B | ||
-0.61% | +2.41% | -24.55% | +66.58% | 4.62B | ||
+1.65% | +1.44% | -2.16% | -10.44% | 3.58B | ||
0.00% | +1.24% | -14.84% | -23.32% | 3.49B | ||
Average | +0.39% | +1.92% | +10.98% | +18.64% | 6.8B | |
Weighted average by Cap. | +0.42% | +1.92% | +13.91% | +19.32% |
2024 * | 2025 * | |
---|---|---|
Net sales | 3.02B 2.93B 2.75B 2.47B 4.34B 261B 4.85B 33.62B 12.5B 107B 11.32B 11.08B 468B | 3.13B 3.04B 2.85B 2.56B 4.5B 271B 5.03B 34.86B 12.96B 111B 11.74B 11.49B 486B |
Net income | 1.54B 1.5B 1.4B 1.26B 2.22B 134B 2.48B 17.18B 6.39B 54.63B 5.78B 5.66B 239B | 1.46B 1.42B 1.33B 1.19B 2.1B 126B 2.35B 16.26B 6.04B 51.69B 5.47B 5.36B 227B |
Net Debt | 13.27B 12.89B 12.09B 10.84B 19.1B 1,149B 21.33B 148B 54.95B 470B 49.77B 48.73B 2,060B | 13.81B 13.42B 12.59B 11.29B 19.88B 1,196B 22.21B 154B 57.21B 489B 51.82B 50.73B 2,145B |
Date | Price | Change | Volume |
---|---|---|---|
25-01-17 | 23.12 $ | +0.54% | 3,156,193 |
25-01-16 | 23.00 $ | +1.50% | 3,854,192 |
25-01-15 | 22.66 $ | +1.03% | 4,083,452 |
25-01-14 | 22.43 $ | +1.49% | 2,940,377 |
25-01-13 | 22.10 $ | +0.55% | 2,861,928 |
Delayed Quote Nasdaq, January 16, 2025 at 04:00 pm EST
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- ARCC Stock